Genome profiling of <it>ERBB2</it>-amplified breast cancers
<p>Abstract</p> <p>Background</p> <p>Around 20% of breast cancers (BC) show <it>ERBB2 </it>gene amplification and overexpression of the ERBB2 tyrosine kinase receptor. They are associated with a poor prognosis but can benefit from targeted therapy. A better knowledge of these BCs, genomically and bi...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2010-10-01
|
| Serier: | BMC Cancer |
| Online adgang: | http://www.biomedcentral.com/1471-2407/10/539 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
